Figure 1From: Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective? Study design with relative time-points. Note that pre-IFNB and low IFNB dose periods had a different duration for each patient, while after switch all patients were followed for 2 years.Back to article page